MedTrace Logo

Prospective Multicenter Registry of Patients With Skin Metastases From Breast Cancer Treated With Electrochemotherapy

NCT06709937 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-11-29

No results posted yet for this study

Summary

Electrochemotherapy (ECT) has been proposed as a new therapeutic option for palliating cutaneous metastases from breast carcinoma.

Conditions

  • Breast Cancer Female

Interventions

OTHER

Prospective multicenter registry of patients with cutaneous metastases from breast carcinoma treated with electrochemotherapy.

electrochemotherapy.

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Giacomo Corrado · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2023-01-31
Completion
2023-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06709937 on ClinicalTrials.gov